An Exclusive Agreement for the Commercialization of Multiple Biosimilars is Signed by Bioventure, Minapharm Pharmaceuticals, and MiGenTra
Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH (https://www.MiGenTra.com), a Berlin-based pharmaceutical company, announced ...